<?xml version="1.0"?>
<Articles JournalTitle="Current Journal of Neurology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A review on adult pragmatic assessments.</title>
    <FirstPage>113</FirstPage>
    <LastPage>118</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Davood</FirstName>
        <LastName>Sobhani Rad</LastName>
        <affiliation locale="en_US">Department of Speech Therapy, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Pragmatics is defined as appropriate use of language either to comprehend ideas or to interact in social situations effectively. Pragmatic competence, which is processed in the right hemisphere, comprises a number of interrelated skills that manifest in a range of adaptive behaviors. Due to the widespread influence of language in communication, studying pragmatic profiles, by developing appropriate tools, is of importance. Here, a range of pragmatic theories and assessment instruments available for use in adult patients is reviewed.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/610</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/610/192</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Cardiovascular effects of fingolimod: A review article.</title>
    <FirstPage>119</FirstPage>
    <LastPage>126</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mohaddeseh</FirstName>
        <LastName>Behjati</LastName>
        <affiliation locale="en_US">Department of Cardiology, School of Medicine, Cardiovascular Research Center AND Heart Failure Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Etemadifar</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Abdar Esfahani</LastName>
        <affiliation locale="en_US">Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Multiple sclerosis (MS) is a chronic auto-immune disease. Most therapeutic strategies for treatment of this disease direct immune modulation and control of inflammatory processes. First-line therapeutic agents showed moderate efficacy and frequent side-effects with moderate efficacy in trials. Their parental administration and limited long-term adherence restrict their efficacy compared with second-line therapies. Fingolimod as a second-line therapeutic agent has been shown to reduce annualized relapse rate, risk of disability progression and inflammatory activity of relapsing MS. Safety and efficacy FTY720: Safety and efficacy issues are the main metrics for judgment of drug efficacy. In this article, we focus on cardiovascular effects of FTY720 treatment. Effect of FTY720 on rate and rhythm, impact of FTY720 on endothelial cells, its atheroprotective effects, its effects on cardiac transplantation outcomes, vascular complications of FTY720, effects of FTY720 on endocrine functions and interaction of FTY720 with cardioactive agents are explained in this review article.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/609</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/609/193</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Differentiation of true transient ischemic attack versus transient ischemic attack mimics.</title>
    <FirstPage>127</FirstPage>
    <LastPage>130</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Noureddine</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kavian</FirstName>
        <LastName>Ghandehari</LastName>
        <affiliation locale="en_US">Department of Neurology, Neuro cognitive Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Taghi Shakeri</LastName>
        <affiliation locale="en_US">Department of Social Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Previous literatures have shown a transient ischemic attack&#xA0; (TIA) mimic rate&#xA0; of 9-31%. We aimed&#xA0; to ascertain the proportion of stroke mimics amongst suspected TIA patients. Methods: A prospective observational study was performed in&#xA0;&#xA0; Ghaem&#xA0;&#xA0; Hospital,&#xA0;&#xA0; Mashhad,&#xA0;&#xA0; Iran&#xA0;&#xA0; during&#xA0;&#xA0; 2012-2013. Consecutive TIA patients&#xA0; were identified in a stroke center. The&#xA0; initial diagnosis&#xA0; of TIA&#xA0; was made&#xA0; by the&#xA0; resident&#xA0; of neurology and final diagnosis of true TIA versus TIA mimics was made after 3 months follow-up by stroke subspecialist. 
Results: A total of 310 patients&#xA0; were assessed&#xA0; during a 3- month period of which 182 (58.7%) subjects were male and 128 (41.3%) were female. Ten percent&#xA0; of the patients&#xA0; was categorized&#xA0; as a TIA mimic. The presence&#xA0; of hypertension, aphasia, duration of symptoms, and increased age was the strongest predictor&#xA0; of a true&#xA0; TIA. Migraine was the&#xA0; most common etiology of stroke mimic in our study. 
Conclusion:&#xA0; It&#xA0; seems&#xA0; that&#xA0; many&#xA0; signs&#xA0; and&#xA0; symptoms have low diagno tic&#xA0; usefulness for discrimination of true TIA from non-cerebrovascular events and predictive usefulness of any sign or symptom should be interpreted by a stroke neurologist.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/608</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/608/194</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Pulmonary function tests in patients with amyotrophic lateral sclerosis and the association between these tests and survival.</title>
    <FirstPage>131</FirstPage>
    <LastPage>137</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Seyed-Ali</FirstName>
        <LastName>Javad Mousavi</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Babak</FirstName>
        <LastName>Zamani</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shahab</FirstName>
        <LastName>Shahabi Shahmiri</LastName>
        <affiliation locale="en_US">Department of Scientific Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Rohani</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Gholam Ali</FirstName>
        <LastName>Shahidi</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Elyas</FirstName>
        <LastName>Mostafapour</LastName>
        <affiliation locale="en_US">Department of Scientific Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Helia</FirstName>
        <LastName>Hemasian</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hanieh</FirstName>
        <LastName>Raji</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: The rapidity of progression of amyotrophic lateral sclerosis (ALS) to death or respiratory failure impacts patients, clinicians, and clinical investigators. The aim of this study is to evaluate of the pulmonary function tests (PFTs) in patients with ALS and the association between these PFTs and survival 
Methods: A total of 36 ALS patients who PFTs, including vital capacity (VC), maximum mid-expiratory flow rate (MMEFR), forced vital capacity (FVC), and forced expiratory volume in 1 s (FEV1), were available from the time of diagnosis were included in this study. Nonpulmonary characteristics assessed at the time of PFTs. Data were analyzed using chi-square, Student&#x2019;s independent t-test, Kaplan-Meier, correlation, and receiver operating characteristic (ROC) curve.
Results: The mean age of subjects was 55.36 (SD = 12.24) year, and the male to female ratio was 2.6. Twenty-Cve (69.4%) were died in 5 years period of our study. The mean and median survival time (In months) was calculated as 42.51 (95% co Cdence interval [CI] 33.64- 51.39) and 38 (95% CI 27.23-48.77) months, respectively. The rate of ALS survival was 74% at 1st year, 41% at 3rd year and 10% at 5th year of starting symptoms. The results of Kaplan-Meier test showed survival was significantly longer in the group with PFTs closer to normal. In addition, ROC analysis showed that FVC &lt; 50% could potentially be a predictor of death in ALS patients (P = 0.003, area under curve = 0.649). 
Conclusion: We found single measures of upright FVC, FEV1 to be significantly associated with survival, even after controlling for relevant non-pulmonary patient characteristics. Our study demonstrated that upright FVC, FEV1, VC, and MMEFR are useful non-invasive measures in the prediction of survival in ALS.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/607</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/607/195</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Comparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome.</title>
    <FirstPage>138</FirstPage>
    <LastPage>143</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Samira</FirstName>
        <LastName>Yadegari</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shahriar</FirstName>
        <LastName>Nafissi</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Neda</FirstName>
        <LastName>Kazemi</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Incidence and predominant subtype&#xA0; of Guillain-Barre syndrome (GBS) differs geographically. Electrophysiology has an important&#xA0; role in early diagnosis and&#xA0; prediction&#xA0; of prognosis. This study&#xA0; is conducted to determine the frequent&#xA0; subtype&#xA0; of GBS in a large group of patients&#xA0; in Iran and compare&#xA0; nerve conduction studies in axonal and demyelinating forms of GBS.
Methods:&#xA0;&#xA0; We&#xA0; retrospectively&#xA0;&#xA0; evaluated&#xA0;&#xA0; the&#xA0;&#xA0; medical records and electrodiagnostic study (EDS) of 121 GBS patients&#xA0; who&#xA0; were&#xA0; managed in our&#xA0; hospital&#xA0; during&#xA0; 11 years. After regarding&#xA0; the exclusion criteria, patients classified as three groups: acute inflammatory demyelinating&#xA0;&#xA0;&#xA0; polyneuropathy&#xA0;&#xA0; (AIDP),&#xA0;&#xA0; acute&#xA0;&#xA0;&#xA0; motor axonal&#xA0; neuropathy&#xA0; (AMAN),&#xA0; and&#xA0; acute&#xA0;&#xA0; motor&#xA0; sensory axonal neuropathy (AMSAN). The most frequent&#xA0; subtype and then electrophysiological&#xA0; characteristic based on the time&#xA0; of EDS&#xA0; and&#xA0; their&#xA0; cerebrospinal&#xA0; fluid (CSF)&#xA0; profile were assessed.
Results: Among 70 patients&#xA0; :nally included in the study, 67% w re&#xA0; men. About&#xA0; 63%, 23%, and&#xA0; 14% had&#xA0; AIDP, AMAN,&#xA0; and&#xA0; AMSAN, respectively.AIDP&#xA0; patients represented a wider range&#xA0; of ages compared&#xA0; with other groups.&#xA0; Higher&#xA0; levels&#xA0; of&#xA0; CSF protein,&#xA0; abnormal&#xA0;&#xA0; late responses&#xA0; and sural sparing were more frequent&#xA0; in AIDP subtype. Five AMSAN patients&#xA0; also revealed sural sparing. Conduction&#xA0;&#xA0; block&#xA0; (CB)&#xA0;&#xA0; was&#xA0; observed&#xA0;&#xA0; in&#xA0; one&#xA0;&#xA0; AMAN patient. Prolonged&#xA0; F-wave latency was observed&#xA0; only in AIDP cases. CB and inexcitable sensory nerves were more frequent&#xA0; after 2 weeks, but&#xA0; reduced&#xA0; F-wave persistency was more prominent in the early phase.
Conclusion: AIDP was the most frequent&#xA0; subtype. Although&#xA0; the&#xA0; electrophysiology&#xA0; and&#xA0; CSF are&#xA0; important diagnostic tools, classification should not be made based on a distinct finding.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/606</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/606/196</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association between non-alcoholic fatty liver disease and ischemic stroke.</title>
    <FirstPage>144</FirstPage>
    <LastPage>148</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Hanieh</FirstName>
        <LastName>Moshayedi</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Tabriz University of Medical Science, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Ahrabi</LastName>
        <affiliation locale="en_US">Department of Radiology, School of Medicine, Tabriz University of Medical Science, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Afshin</FirstName>
        <LastName>Mardani</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Tabriz University of Medical Science, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Saieed</FirstName>
        <LastName>Sadigetegad</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Tabriz University of Medical Science, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Farhudi</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Neurosciences Research Center, Student Research Committee, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Some studies&#xA0; in recent&#xA0; years showed&#xA0; that carotid&#xA0; intima-media&#xA0;&#xA0; thickness&#xA0; (IMT),&#xA0; indicator&#xA0; of&#xA0; the presence&#xA0; of atherosclerosis,&#xA0; was higher&#xA0; in non-alcoholic fatty&#xA0; liver disease&#xA0; (NAFLD)&#xA0; in comparison&#xA0; with&#xA0; normal subjects.&#xA0; They concluded&#xA0; that&#xA0; NAFLD&#xA0; patients&#xA0; may&#xA0; be resulted&#xA0; in more cardiovascular events. Hence, we aimed to study the association of NAFLD and ischemic stroke.
Methods: For this reason, 110 brain magnetic&#xA0; resonance imaging&#xA0;&#xA0; confirmed&#xA0;&#xA0; ischemic&#xA0; stroke&#xA0;&#xA0; patients&#xA0;&#xA0; and&#xA0;&#xA0; 110 patients&#xA0; age and sex matched&#xA0; controls went through&#xA0; liver ultrasound&#xA0;&#xA0;&#xA0; to&#xA0;&#xA0; detect&#xA0;&#xA0;&#xA0; NAFLD&#xA0;&#xA0;&#xA0; and&#xA0;&#xA0;&#xA0; common&#xA0;&#xA0;&#xA0; carotid ultrasound&#xA0; to measure IMT. Demographic and vascular risk factors were detailed for all subjects.
Results: NAFLD was found in 47 (42.7%) of ischemic stroke patients&#xA0; and 25 (22.7%) of controls. By adjusting&#xA0; sex and age&#xA0; in table&#xA0; 2, odds&#xA0; ratio (OR) for NAFLD was 2.15 (95% con&lt;dence&#xA0; interval [CI]: 1.25-3.71) that was statistically significant (P = 0.006). However, after adjusting&#xA0; for other confounding&#xA0; risk factors&#xA0; (waist&#xA0; circumference, hypertension, diabetes&#xA0; mellitus, low-density lipoprotein, triglyceride, alanine aminotransferase, aspartate aminotransferase, creatine, body mass index, cigarette smoking, and ischemic heart disease), the OR decrease&#xA0; to 1.68 (95% CI: 0.42-6.76) that was not statistically signi&lt;cant (P = 0.460). The OR for IMT of right and left common carotid was 1.23 (95% CI: 0.48-3.15) and&#xA0; 1.24 (95% CI: 0.57-2.69), respectively that none of them were statistically significant.
Conclusion: Although&#xA0; the&#xA0; risk of occurrence&#xA0; of ischemic stroke is higher in NAFLD patients, but NAFLD is not associated independently with ischemic stroke.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/605</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/605/197</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effect of Boswellia papyrifera on cognitive impairment in multiple sclerosis.</title>
    <FirstPage>149</FirstPage>
    <LastPage>153</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Behnaz</FirstName>
        <LastName>Sedighi</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Pardakhty</LastName>
        <affiliation locale="en_US">Department of Pharmacology ,School of Pharmacy, Pharmaceutics Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hoda</FirstName>
        <LastName>Kamali</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kaveh</FirstName>
        <LastName>Shafiee</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Bahar Naz</FirstName>
        <LastName>Hasani</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Cognitive&#xA0; impairment&#xA0; is one of the&#xA0; most crucial disorders&#xA0; among&#xA0; multiple&#xA0; sclerosis (MS) patients. Since&#xA0; MS&#xA0; is&#xA0; an inflammatory disease&#xA0;&#xA0; and&#xA0;&#xA0; Boswellia papyrifera has anti-inflammatory effects, the influence of B. papyrifera&#xA0; on&#xA0; cognitive&#xA0; impairment&#xA0;&#xA0; in&#xA0; MS patients&#xA0;&#xA0; has been investigated&#xA0; in the present study.
Methods: In this clinical trial, 80 MS patients&#xA0; who referred to the clinic of Shafa Hospital, Kerman, Iran were selected. Having completed a written&#xA0; consent&#xA0; form, patients&#xA0; with relapsing remitting MS, with no occurrence of a new attack throughout 1 month&#xA0; before the study, with no pregnancy or breastfeeding entered the study. The patients&#xA0; were randomly divided into two groups; then Brief International Cognitive Assessment for MS (BICAMS) test was carried out. One group received B. papyrifera (capsule 300 mg, twice a day) while the other group received placebo with the same dose&#xA0; for 2 months. After 2 months&#xA0; of treatment, BICAMS was redone&#xA0; and&#xA0; changes&#xA0; were&#xA0; analyze .The significant change value on the before-after BICAMS points were considered&#xA0; to be 8, 13, and 7 points for the symbol digit modality&#xA0; test (SDMT),&#xA0; the&#xA0; California verbal&#xA0; learning&#xA0; test (CVLT),&#xA0; and&#xA0; the&#xA0; brief visual-spatial&#xA0; memory&#xA0; test&#xA0; revised (BVMT-R), respectively.
Results:&#xA0; The&#xA0; patients&#x2019;&#xA0; mean&#xA0; age&#xA0; was 36.58&#xA0;&#xA0;&#xA0;&#xA0; 8.50&#xA0; years. The mean duration of disease was 7.41&#xA0;&#xA0;&#xA0; 4.13 years. About 84.2% (n = 64) of the patients&#xA0; was female. In the BVMT-R, 13 patients&#xA0; (34.2%), who had&#xA0; already taken&#xA0; B. papyrifera, were shown to have significant improvement compared&#xA0; to the&#xA0; placebo&#xA0; group&#xA0; with&#xA0; no&#xA0; improvement&#xA0; (P &lt;&#xA0; 0.&#xA0; 001). About&#xA0; 12 and&#xA0; 8 patients&#xA0; in the&#xA0; treatment and&#xA0; placebo groups in the SDMT, respectively (P = 0.200) and 17 and 12 patients&#xA0; in the treatment and placebo groups in the CVLT, respectively (P = 0.170) had signi@cant change values.
Conclusion: B. papyrifera showed significant improvement in&#xA0; visuospatial&#xA0; memory,&#xA0; but&#xA0;&#xA0; had&#xA0;&#xA0; no&#xA0; effect&#xA0; on&#xA0; verbal memory and information processing speed.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/604</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/604/198</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effect of NOS3 gene polymorphism on response to Tricyclic antidepressants in migraine attacks.</title>
    <FirstPage>154</FirstPage>
    <LastPage>159</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Aliasghar</FirstName>
        <LastName>Molana</LastName>
        <affiliation locale="en_US">Department of Neuroscience, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Mehrpour</LastName>
        <affiliation locale="en_US">Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nasim</FirstName>
        <LastName>Vousooghi</LastName>
        <affiliation locale="en_US">Department of Neuroscience, School of Advanced Technologies in Medicine AND Genetics Laboratory, Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahmoud Reza</FirstName>
        <LastName>Hajighasem</LastName>
        <affiliation locale="en_US">Department of Neuroscience, School of Advanced Technologies in Medicine AND Brain and Spinal Cord Injury Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Taghi</FirstName>
        <LastName>Joghataei</LastName>
        <affiliation locale="en_US">Department of Neuroscience, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Migraine is a chronic&#xA0; neurological&#xA0; disorder, characterized&#xA0; by recurrent&#xA0; moderate to severe headaches. Worldwide migraine a=ects nearly 15%. Studies suggest that genes involved in the production of nitric oxide (NO) may act as genetic&#xA0; factors for migraine. NO synthase&#xA0; 3 (NOS3) by expressing&#xA0; enzyme NOS regulates&#xA0; endothelial&#xA0; derived NO. One&#xA0; class of&#xA0; medications&#xA0;&#xA0; used&#xA0; as&#xA0; first-line treatment in migraine prophylaxis is tricyclic antidepressants (TCAs). The aim of this study&#xA0; was to determine&#xA0; e=ects&#xA0; of NOS3 gene Glu298Asp polymorphism&#xA0; in&#xA0; the&#xA0; production&#xA0; of&#xA0; NO and response of patients to TCAs in migraine attacks.
Methods: A total of 80 migraine patients&#xA0; were invited to participate&#xA0;&#xA0; in&#xA0; the&#xA0; study.&#xA0; Patients&#xA0; recorded&#xA0;&#xA0; the characteristics of their migraine attacks such as frequency of attacks and intensity of headaches for the 1st&#xA0; month&#xA0; of the study. Then peripheral blood samples were taken from all subjects in order to determine patients&#x2019; genotype distribution,&#xA0; mRNA&#xA0; expression&#xA0; level&#xA0; of&#xA0; NOS3 and&#xA0;&#xA0; NO content&#xA0; of plasma. Patients were then instructed&#xA0; to use 25 mg nortriptyline at night before bed for 3 months. At the end of 3rd&#xA0; month of the treatment patients&#xA0; again recorded the&#xA0; migraine characteristics&#xA0; for&#xA0; 1&#xA0; month&#xA0;&#xA0; and&#xA0;&#xA0; blood sampling was performed&#xA0; in order to determine the level of plasma NO.
Results: The patients&#x2019; genotype distribution&#xA0; for TT,&#xA0; GT, and GG was 9, 24, and 47 subjects, respectively. Mean NO level in patients&#xA0; with TT genotype was less in comparison to GT and GG genotypes before and after use of TCAs (P &lt; 0.05). Mean&#xA0; intensity&#xA0; of headaches in patients&#xA0; with&#xA0; TT genotype&#xA0; was&#xA0; lower&#xA0; in&#xA0; comparison&#xA0;&#xA0; to&#xA0;&#xA0; GT&#xA0;&#xA0; and&#xA0;&#xA0; GG genotypes before and after use of TCAs (based on verbal numerical&#xA0;&#xA0; rating&#xA0;&#xA0; scale).&#xA0; Mean&#xA0; frequency&#xA0;&#xA0; of&#xA0; migraine attacks after use of TCAs was significantly decreased in all genotypes of NOS3 Glu298Asp polymorphism particularly in TT genotype (P &lt; 0.05).
Conclusion: Presence of T allele of the Glu298Asp polymorphism may be a factor for TT genotype patients to produce less NO and is a favorable factor for better response to TCAs in reducing&#xA0; migraine&#xA0; attacks in comparison to GT and GG genotypes.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/603</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/603/199</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.</title>
    <FirstPage>160</FirstPage>
    <LastPage>167</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Roya</FirstName>
        <LastName>Abolfazli</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Amiralam Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Azam</FirstName>
        <LastName>Elyasi</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Javadi</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kheirollah</FirstName>
        <LastName>Gholami</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Torkamandi</LastName>
        <affiliation locale="en_US">Department of Pharmaceutical Care, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Amir-Shahkarami</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Etemadifar</LastName>
        <affiliation locale="en_US">Department of Neurology, Isfahan Neurosciences Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Nasr</LastName>
        <affiliation locale="en_US">Department of Medicine, Medical Students' Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background:&#xA0; Multiple&#xA0; sclerosis&#xA0; (MS) patients permanently confronted&#xA0; with serious challenges from treatment regimen. Developing&#xA0; a new&#xA0; questionnaire in MS management, through&#xA0; evaluation&#xA0; of patients&#x2019; perspectives&#xA0;&#xA0; and&#xA0; knowledge&#xA0;&#xA0; regarding&#xA0;&#xA0; treatment&#xA0; will help&#xA0; to&#xA0; identify the&#xA0; sources&#xA0; of tension, and&#xA0; to&#xA0; build&#xA0; a therapeutic&#xA0;&#xA0; alliance.&#xA0;&#xA0; We&#xA0;&#xA0; purposed&#xA0;&#xA0; to&#xA0;&#xA0; describe&#xA0;&#xA0;&#xA0; MS patients&#x2019; understanding of their treatments.
Methods: About 425 completed and returned questionnaire were assessed&#xA0; of a total of 500 recruited&#xA0; MS patients. The knowledge&#xA0;&#xA0; of&#xA0; correct&#xA0; using&#xA0; interferon-beta&#xA0; (IFN-&#x3B2;)&#xA0; and attitude&#xA0;&#xA0; toward&#xA0; medical&#xA0; care&#xA0; were&#xA0; assessed&#xA0;&#xA0; using&#xA0; self- reported questionnaires consisted of 25 items with validity of multidisciplinary panel and pre-testing on 20 patients.
Results:&#xA0; Knowledge&#xA0; about&#xA0; IFN-&#x3B2;&#xA0; therapy&#xA0; was&#xA0; very low; however, attitude&#xA0; was at a high level. Female patients, self- injection ability, higher educational level, normal functional status, delay from the start of diagnostic workup to definite diagnosis, and being younger were related to a higher level of&#xA0; knowledge.&#xA0; Attitude&#xA0; was&#xA0; associated&#xA0;&#xA0; with&#xA0; functional status,&#xA0; family&#xA0; history&#xA0; of&#xA0; disease&#xA0;&#xA0; and&#xA0;&#xA0; the&#xA0;&#xA0; summary&#xA0; of knowledge variable.
Conclusion: Developing educational&#xA0; interventions&#xA0; are needed for MS patients&#xA0; regarding&#xA0; to&#xA0; their&#xA0; low levels of knowledge.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/602</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/602/200</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association of interleukin 7 receptor gene polymorphism rs6897932 with multiple sclerosis patients in Khuzestan.</title>
    <FirstPage>168</FirstPage>
    <LastPage>171</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mahshid</FirstName>
        <LastName>Hosseini Behbahani</LastName>
        <affiliation locale="en_US">Department of Biochemistry, Payame Noor University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hamid</FirstName>
        <LastName>Galehdari</LastName>
        <affiliation locale="en_US">Departmanet of Genetic, School of Sciences, Shahid Chamran University, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Mohaghegh</LastName>
        <affiliation locale="en_US">Departmanet of Genetic, School of Sciences, Shahid Chamran University, Ahvaz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background:&#xA0; Multiple&#xA0; sclerosis&#xA0; (MS) is a&#xA0; chronic inflammatory&#xA0; demyelinating&#xA0; and&#xA0; neurodegenerative disease&#xA0; of central&#xA0; nervous&#xA0; system&#xA0; with unknown&#xA0; causes. Etiology of MS involves&#xA0; both&#xA0; genetic&#xA0; and&#xA0; environment factors.&#xA0; The&#xA0; interleukin&#xA0; 7 &#xA0; receptor&#xA0;&#xA0; (IL7R)&#xA0;&#xA0; gene&#xA0;&#xA0; is&#xA0; a promising candidate&#xA0; for MS, because its involvement in the autoimmunity, regulation of the T-cell homeostasis, proliferation, and anti-apoptotic signaling.
Methods: We investigated&#xA0; the association of the IL7R gene polymorphism&#xA0; rs6897932&#xA0; in MS patients&#xA0;&#xA0; in a&#xA0; case&#xA0; and control study. In this case and control study participating, 127&#xA0; relapsing-remitting&#xA0; MS (RRMS)&#xA0; patients&#xA0;&#xA0; (mean&#xA0; age: 32.25, age range: 16-57) selected&#xA0; according McDonald criteria, and 109 ethnically, sex and age matched&#xA0; healthy control&#xA0;&#xA0; (mean&#xA0; age:&#xA0; 27.44,&#xA0; age&#xA0;&#xA0; range:&#xA0; 14-63)&#xA0; with&#xA0; no personal&#xA0; or family history of autoimmune diseases&#xA0; were studied. DNA was extracted&#xA0; from whole blood using high pure&#xA0; polymerase&#xA0; chain reaction&#xA0; template preparatio&#xA0; kit from&#xA0; Roch&#xA0; Company.&#xA0; Amplification refractory&#xA0; mutation system method was applied to define the genotyping C/T within exon 6 of the IL7R gene among individuals.
Results: Evaluation&#xA0;&#xA0; of&#xA0; the&#xA0;&#xA0; IL7R&#xA0;&#xA0; gene&#xA0;&#xA0; polymorphism revealed&#xA0; that&#xA0; the&#xA0; T allele and the&#xA0; C/T and T/T genotypes are present&#xA0; in 53.5%, 42.5%, 4.0%, and 68.8%, 26.6%, 4.6% in&#xA0; MS patients&#xA0;&#xA0; and&#xA0;&#xA0; controls,&#xA0; respectively.&#xA0; Comparison between alleles and&#xA0; genotypes in the&#xA0; MS patients&#xA0; and healthy controls show significant differences (P = 0.038).
Conclusion: The distribution of&#xA0; the rs6897932 polymorphism&#xA0; is significantly different in our case/control study&#xA0; in Khuzestan &#xA0; Province.&#xA0; This&#xA0; single&#xA0; nucleotide polymorphism&#xA0; causes alternative&#xA0; splicing in exon 6 of the IL7R gene with possible influence of the autoimmunity.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/601</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/601/201</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Seizures and movement disorders induced by hyperglycemia without ketosis in elderly.</title>
    <FirstPage>172</FirstPage>
    <LastPage>176</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Samia</FirstName>
        <LastName>Younes</LastName>
        <affiliation locale="en_US">Department of Endocrinology and Internal Medicine, School of Medicine, University of Monastir, Al Munast&#xEE;r, Tunisia.</affiliation>
      </Author>
      <Author>
        <FirstName>Yousra</FirstName>
        <LastName>Cherif</LastName>
        <affiliation locale="en_US">Department of Endocrinology and Internal Medicine, School of Medicine, University of Monastir, Al Munast&#xEE;r, Tunisia.</affiliation>
      </Author>
      <Author>
        <FirstName>Mouna</FirstName>
        <LastName>Aissi</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, University of Monastir, Al Munast&#xEE;r, Tunisia.</affiliation>
      </Author>
      <Author>
        <FirstName>Wafa</FirstName>
        <LastName>Alaya</LastName>
        <affiliation locale="en_US">Department of Endocrinology and Internal Medicine, School of Medicine, University of Monastir, Al Munast&#xEE;r, Tunisia.</affiliation>
      </Author>
      <Author>
        <FirstName>Olfa</FirstName>
        <LastName>Berriche</LastName>
        <affiliation locale="en_US">Department of Endocrinology and Internal Medicine, School of Medicine, University of Monastir, Al Munast&#xEE;r, Tunisia.</affiliation>
      </Author>
      <Author>
        <FirstName>Amel</FirstName>
        <LastName>Boughammoura</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, University of Monastir, Al Munast&#xEE;r, Tunisia.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahbouba</FirstName>
        <LastName>Frih-Ayed</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, University of Monastir, Al Munast&#xEE;r, Tunisia.</affiliation>
      </Author>
      <Author>
        <FirstName>Baha</FirstName>
        <LastName>Zantour</LastName>
        <affiliation locale="en_US">Department of Endocrinology and Internal Medicine, School of Medicine, University of Monastir, Al Munast&#xEE;r, Tunisia.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohamed</FirstName>
        <LastName>Habib Sfar</LastName>
        <affiliation locale="en_US">Department of Endocrinology and Internal Medicine, School of Medicine, University of Monastir, Al Munast&#xEE;r, Tunisia.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Non-ketotic hyperglycemia (NKHG) may increase the probability of seizures and movement disorders. Methods: We describe&#xA0; a series of 14 elders admitted for seizures and movement disorders linked to NKHG.
Results: Twelve&#xA0; patients&#xA0; developed motor&#xA0; seizures&#xA0; and two others movement disorders. Glucose levels varied 9.28 to 32 mmol/l, while osmolarity values varied from 302.28 to 328&#xA0; mosmol/l. All patients&#xA0; responded&#xA0; well&#xA0; to&#xA0; insulin therapy and four of them needed anti-epileptic drugs.
Conclusion:&#xA0; Seizures or&#xA0; movement disorders&#xA0; in elderly with&#xA0;&#xA0; NKHG could be&#xA0; misdiagnosed as neurological diseases. Blood&#xA0; glucose must&#xA0; be audited&#xA0; whenever patients with seizures&#xA0;&#xA0; or&#xA0;&#xA0; movement disorders&#xA0; are encountered, as the condition&#xA0; may quickly resolve when NKHG is controlled.
Introduction: Seizures and movement disorders related to non- ketotic hyperglycemia (NKHG) have been reported with increasing frequency since the first case documented in 1965.1,2 The clinical spectr m of this syndrome is various with a severe course in elderly. It develops more&#xA0; quickly&#xA0;&#xA0; than other disorders of diabetes&#xA0; mellitus&#xA0; with&#xA0; hyperglycemia,&#xA0; but&#xA0; usually without&#xA0; evidence&#xA0; of&#xA0; ketosis.2,3 Since&#xA0; the&#xA0; syndrome often ensues during the course of any illness and yet has&#xA0; not&#xA0; been&#xA0; reported&#xA0; in&#xA0; diverse&#xA0; medical&#xA0; fields, doctors must become familiar with this preventable condition, especially in elders. Thus, only the prompt institution of appropriate&#xA0; insulin&#xA0; therapy&#xA0; will improve prognosis and hasten recovery.2,3</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/600</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/600/202</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Morning glory syndrome associated with multiple sclerosis.</title>
    <FirstPage>177</FirstPage>
    <LastPage>180</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Anahid</FirstName>
        <LastName>Safari</LastName>
        <affiliation locale="en_US">Clinical Neurology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Esmail</FirstName>
        <LastName>Jafari</LastName>
        <affiliation locale="en_US">Department of Ophthalmology, Division of Corneal Disease, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Afshin</FirstName>
        <LastName>Borhani-Haghighi</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine AND Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Morning glory syndrome (MGS) is a rare congenital optic disc anomaly characterized by a funnel-shaped, excavated optic disc surrounded by chorioretinal pigmentary disturbance. The main ophthalomoscopic feature of the MGS is enlarged optic disc with a funnel shaped scleral defect; elevated peripapillary chorioretinal pigmentation; and pale fluffy tissue of glial hyperplasia overlying the optic disc. Although most of the reported cases were isolated ocular abnormality, but it may occurs in association with other ophthalmic abnormalities such as cyst of the optic nerve atrophy, congenital cataract, microophthalmos, and aniridia. Craniofacial deformities such as cleft lip and palate, hypertelorism, dysplatic ears; renal abnormalities; and cardiac defects have also been reported with MGS. Herein, we present a case of MGS associated with multiple sclerosis - a rather unusual concurrence.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/599</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/599/203</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Cerebral abscess complicating embolization of an arteriovenous malformation: Case report and review of litera.</title>
    <FirstPage>181</FirstPage>
    <LastPage>184</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Khoshnevisan</LastName>
        <affiliation locale="en_US">Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Askar</FirstName>
        <LastName>Ghorbani</LastName>
        <affiliation locale="en_US">Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Narges</FirstName>
        <LastName>Sistany Allahabadi</LastName>
        <affiliation locale="en_US">Student of Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farshid</FirstName>
        <LastName>Farzaneh</LastName>
        <affiliation locale="en_US">Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sina</FirstName>
        <LastName>Abdollahzadeh</LastName>
        <affiliation locale="en_US">Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sepehr</FirstName>
        <LastName>Soleymani</LastName>
        <affiliation locale="en_US">Student of Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Vahidreza</FirstName>
        <LastName>Ostovan</LastName>
        <affiliation locale="en_US">Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences AND Iranian Center of Neurological Research, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Central nervous system infection is a rare complication of endovascular procedures. We report a 21-year-old woman presented with headache, nausea, vomiting, and right-sided hemiparesis 4 months after endovascular embolization of cerebral arteriovenous malformation. Investigations led to the diagnosis of multiple brain abscesses. This is the sixth case report of brain abscess following endovascular interventions.</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/598</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/598/204</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Management of myogenic ptosis in chronic progressive external ophtalmoplegia.</title>
    <FirstPage>185</FirstPage>
    <LastPage>187</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mohammad Taher</FirstName>
        <LastName>Rajabi</LastName>
        <affiliation locale="en_US">Department of Ophthalmology, School of Medicine, Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Ziaeddin</FirstName>
        <LastName>Tabatabaie</LastName>
        <affiliation locale="en_US">Department of Ophthalmology, School of Medicine, Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Bagher</FirstName>
        <LastName>Rajabi</LastName>
        <affiliation locale="en_US">Department of Ophthalmology, School of Medicine, Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Yalda</FirstName>
        <LastName>Abrishami</LastName>
        <affiliation locale="en_US">Department of Ophthalmology, School of Medicine, Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyedeh Simindokht</FirstName>
        <LastName>Hosseini</LastName>
        <affiliation locale="en_US">Department of Ophthalmology, School of Medicine, Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>James</FirstName>
        <LastName>Oestreicher</LastName>
        <affiliation locale="en_US">Department of Ophthalmology and Vision Sciences, School of Medicine, University of Toronto, Toronto, Canada.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">No Abstract</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/597</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/597/205</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Thinking outside the cranium.</title>
    <FirstPage>188</FirstPage>
    <LastPage>190</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Anahita</FirstName>
        <LastName>Sadeghi</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, School of Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Behrouz</FirstName>
        <LastName>Navabakhsh</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, School of Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>Aghaghazvini</LastName>
        <affiliation locale="en_US">Department of Radiology, School of Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">No Abstract</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/596</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/596/206</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Ability to gain religious experiences as a part of cognitive abilities.</title>
    <FirstPage>191</FirstPage>
    <LastPage>192</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Abdorreza</FirstName>
        <LastName>Naser Moghadasi</LastName>
        <affiliation locale="en_US">Department of Neurology, School of Medicine, MS Research Center, Neuroscience Institute, Sina Hospital, Tehran University of Medical Science, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">No Abstract</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/595</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/595/207</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Current Journal of Neurology</JournalTitle>
      <Issn>2717-011X</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The first international and the sixth national Iranian stroke congress event report.</title>
    <FirstPage>193</FirstPage>
    <LastPage>194</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Farhoudi</LastName>
        <affiliation locale="en_US">Neuroscience Research center, Tabriz University of Medical sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kaveh</FirstName>
        <LastName>Mehrvar</LastName>
        <affiliation locale="en_US">Neuroscience Research center, Tabriz University of Medical sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hadiseh</FirstName>
        <LastName>Kavandi</LastName>
        <affiliation locale="en_US">Neuroscience Research center, Tabriz University of Medical sciences, Tabriz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Arash</FirstName>
        <LastName>Aslanabadi</LastName>
        <affiliation locale="en_US">Neuroscience Research center, Tabriz University of Medical sciences, Tabriz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">No Abstract</abstract>
    <web_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/view/594</web_url>
    <pdf_url>https://ijnl.tums.ac.ir/index.php/ijnl/article/download/594/208</pdf_url>
  </Article>
</Articles>
